Thomas Smith
Stock Analyst at Leerink Partners
(4.98)
# 67
Out of 5,044 analysts
692
Total ratings
54.5%
Success rate
47.7%
Average return
Main Sectors:
Stocks Rated by Thomas Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MLTX MoonLake Immunotherapeutics | Reiterated: Buy | $14 → $30 | $10.82 | +177.26% | 33 | Oct 1, 2026 | |
| SGMT Sagimet Biosciences | Reiterated: Buy | n/a | $8.93 | - | 16 | Oct 1, 2026 | |
| IVA Inventiva | Reiterated: Buy | $12 | $3.16 | +279.75% | 2 | Sep 29, 2026 | |
| CLDX Celldex Therapeutics | Reiterated: Buy | $70 → $88 | $29.89 | +194.41% | 42 | Sep 23, 2026 | |
| EVMN Evommune | Rated: Buy | $52 → $22 | $6.25 | +252.00% | 3 | Sep 10, 2026 | |
| IRON Disc Medicine | Reiterated: Buy | $100 | $62.06 | +61.13% | 28 | Sep 10, 2026 | |
| SYRE Spyre Therapeutics | Rated: Buy | $106 → $128 | $85.69 | +49.38% | 2 | Sep 10, 2026 | |
| KROS Keros Therapeutics | Reiterated: Buy | $35 → $23 | $11.95 | +92.47% | 53 | Aug 4, 2026 | |
| ALT Altimmune | Reiterated: Buy | $10 | $2.61 | +283.14% | 2 | Jul 28, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $780 → $1,065 | $825.03 | +29.09% | 36 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $38 | $13.65 | +178.39% | 1 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.00 | - | 8 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $2.91 | +312.37% | 1 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 | $1.41 | +325.53% | 34 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.06 | - | 17 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $7.16 | +346.93% | 13 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $18.66 | +167.95% | 39 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $50 | $30.47 | +64.10% | 37 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $9.08 | +296.48% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.87 | - | 20 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $32 | $6.39 | +400.78% | 18 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 102.00 | kr 35.96 | +183.65% | 1 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 | $28.51 | +313.89% | 38 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.98 | - | 3 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.83 | +82.77% | 34 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $104 → $115 | $88.15 | n/a | 17 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $471.75 | n/a | 39 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.48 | n/a | 34 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.34 | n/a | 8 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $14.23 | n/a | 16 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $8.19 | n/a | 28 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $13.19 | n/a | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $33 | $112.40 | n/a | 5 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.29 | n/a | 25 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $1.02 | n/a | 9 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $44.00 | n/a | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $2 | $21.08 | n/a | 16 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 5,295p | 111p | n/a | 1 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $21 | $10.29 | n/a | 1 | Jan 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $6 | $2.06 | n/a | 1 | Sep 8, 2017 |
MoonLake Immunotherapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $14 → $30
Current: $10.82
Upside: +177.26%
Sagimet Biosciences
Oct 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.93
Upside: -
Inventiva
Sep 29, 2026
Reiterated: Buy
Price Target: $12
Current: $3.16
Upside: +279.75%
Celldex Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $70 → $88
Current: $29.89
Upside: +194.41%
Evommune
Sep 10, 2026
Rated: Buy
Price Target: $52 → $22
Current: $6.25
Upside: +252.00%
Disc Medicine
Sep 10, 2026
Reiterated: Buy
Price Target: $100
Current: $62.06
Upside: +61.13%
Spyre Therapeutics
Sep 10, 2026
Rated: Buy
Price Target: $106 → $128
Current: $85.69
Upside: +49.38%
Keros Therapeutics
Aug 4, 2026
Reiterated: Buy
Price Target: $35 → $23
Current: $11.95
Upside: +92.47%
Altimmune
Jul 28, 2026
Reiterated: Buy
Price Target: $10
Current: $2.61
Upside: +283.14%
argenx SE
Jul 24, 2026
Reiterated: Buy
Price Target: $780 → $1,065
Current: $825.03
Upside: +29.09%
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $38
Current: $13.65
Upside: +178.39%
Jun 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $11.00
Upside: -
Jun 2, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $2.91
Upside: +312.37%
May 28, 2026
Upgraded: Buy
Price Target: $6
Current: $1.41
Upside: +325.53%
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.06
Upside: -
May 15, 2026
Reiterated: Buy
Price Target: $32
Current: $7.16
Upside: +346.93%
Apr 6, 2026
Reiterated: Buy
Price Target: $50
Current: $18.66
Upside: +167.95%
Apr 2, 2026
Reiterated: Buy
Price Target: $52 → $50
Current: $30.47
Upside: +64.10%
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $36
Current: $9.08
Upside: +296.48%
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.87
Upside: -
Dec 15, 2025
Reiterated: Buy
Price Target: $25 → $32
Current: $6.39
Upside: +400.78%
Nov 26, 2025
Initiated Coverage: Buy
Price Target: kr 102.00
Current: kr 35.96
Upside: +183.65%
Oct 23, 2025
Reiterated: Buy
Price Target: $118
Current: $28.51
Upside: +313.89%
Oct 21, 2025
Reiterated: Buy
Price Target: n/a
Current: $2.98
Upside: -
Oct 15, 2025
Reiterated: Buy
Price Target: $7
Current: $3.83
Upside: +82.77%
Oct 8, 2025
Reiterated: Buy
Price Target: $104 → $115
Current: $88.15
Upside: n/a
Aug 19, 2025
Reiterated: Buy
Price Target: n/a
Current: $471.75
Upside: n/a
Aug 15, 2025
Reiterated: Buy
Price Target: $8
Current: $2.48
Upside: n/a
Apr 16, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.34
Upside: n/a
Aug 28, 2024
Reiterated: Buy
Price Target: $58
Current: $14.23
Upside: n/a
Aug 8, 2024
Reiterated: Hold
Price Target: $5
Current: $8.19
Upside: n/a
Aug 8, 2024
Reiterated: Buy
Price Target: $6
Current: $13.19
Upside: n/a
Aug 7, 2024
Reiterated: Hold
Price Target: $33
Current: $112.40
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $7
Current: $3.29
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $46
Current: $1.02
Upside: n/a
Mar 15, 2024
Reiterated: Buy
Price Target: n/a
Current: $44.00
Upside: n/a
Aug 15, 2023
Downgraded: Hold
Price Target: $13 → $2
Current: $21.08
Upside: n/a
Aug 8, 2022
Reiterated: Buy
Price Target: 5,295p
Current: 111p
Upside: n/a
Jan 17, 2019
Initiated Coverage: Hold
Price Target: $21
Current: $10.29
Upside: n/a
Sep 8, 2017
Initiated Coverage: Hold
Price Target: $6
Current: $2.06
Upside: n/a